摘要
目的观察LAK细胞治疗组(150例)与对照组(120例)治疗慢性乙型肝炎10年内的疗效。方法两组病人分别在治疗结束后及1、2、3、5、7、10年内检查肝功能,HBVM、PCR—HBV—DNA、肝脏B超、X-线食道钡餐透视、肝癌发生人数和病死人数。结果治疗组上述指标较对照组有显著差异(x^2检验)。治疗组死亡1例,对照组死亡46例;治疗组无肝癌发生,对照组有12例发生肝癌。结论 LAK细胞治疗慢性乙肝10年内疗效较好。
To observe the effect of the cases with chronic hepatitis between the treated group (150 cases) and the controlled group (120 cases) within ten gears. Methods The patients of the two groups were examined within one, two, three, five, seven and ten years after the treatment by hepatic function, HBVM, PCR - HBV - DNA, hepatic ultrasonic B, x - ray, esophageal barium meal fluoroscopy, number of hepatic cancer incidence and number of patient death rate. Results As for the indexes mentioned above there was remarkable difference in the treated group, as compared with that in the control group (x2 test). One death occurred in the treated group, 46 deaths in the control group; No hepatic cancer appeared in the treated group, 12 hepatic cancer patients took place in the conitrol group. Conclusion It has better effect to treat chronic hepatitis B within 10 years by LAK cells.
出处
《传染病信息》
2001年第3期125-126,共2页
Infectious Disease Information
